Patient Characteristics, Safety, and Tolerability with Telaprevir Treatment for HCV in the Clinic: a Retrospective, Multicenter Study

BACKGROUND AND AIMS: There is a paucity of information regarding similarities and differences between patients from the phase 3 studies of telaprevir and those receiving telaprevir in clinical practice. METHODS: This retrospective chart review evaluated baseline characteristics and follow-up safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Flamm, Steven L., Pockros, Paul J., Bengtsson, Leif, Friedman, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Ltd 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521261/
https://www.ncbi.nlm.nih.gov/pubmed/26356545
http://dx.doi.org/10.14218/JCTH.2014.00007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521261/
https://www.ncbi.nlm.nih.gov/pubmed/26356545
http://dx.doi.org/10.14218/JCTH.2014.00007

Ejemplares similares